Study confirms long-term benefit of anti-VEGF therapy for age-related macular degeneration
Patients with age-related macular degeneration (AMD), the most common cause of major vision loss in older people, still show benefits from a new class of therapy—originally developed to treat cancer—after long-term treatment.
May 2, 2016